Memantine for the prevention of cognitive dysfunction in patients receiving whole-brain radiotherapy: a randomized, double-blind, placebo-controlled trialPaul D. Brown, Ali Choucair, Sherry Fox et al.|Neuro-Oncology|2013Cited by 942
Hippocampal Avoidance During Whole-Brain Radiotherapy Plus Memantine for Patients With Brain Metastases: Phase III Trial NRG Oncology CC001Paul D. Brown, Vinai Gondi, Stephanie L. Pugh et al.|Journal of Clinical Oncology|2020Cited by 827
FLASH radiotherapy for the treatment of symptomatic bone metastases in the thorax (FAST-02): protocol for a prospective study of a novel radiotherapy approachEmily Daugherty, John P. Perentesis, Ye Zhang et al.|Radiation Oncology|2024Cited by 90
FLASH Radiotherapy for the Treatment of Symptomatic Bone Metastases (FAST-01): Protocol for the First Prospective Feasibility StudyEmily Daugherty, John C. Breneman, Anthony Mascia et al.|JMIR Research Protocols|2022Cited by 88